期刊文献+

反相高效液相色谱法测定人血浆中头孢地尼的浓度 被引量:2

Determination of Cefdinir in Human Plasma by RP-HPLC
在线阅读 下载PDF
导出
摘要 目的:建立人血浆中头孢地尼浓度的反相高效液相色谱测定方法。方法:以甲硝唑为内标,血浆样品经三氯乙酸(TCA)沉淀蛋白处理,色谱柱为Nucleodur C_(18)(250mm×4.6 mm,5μm),保护柱为自填C_(18)柱,流动相为0.025 mol·L^(-1)磷酸二氢铵溶液(pH 3.0)-乙腈(90.5∶9.5),检测波长为286nm,流速为1.0 ml·min^(-1)。结果:头孢地尼的线性范围为0.05~2.00μg·ml^(-1)(r=0.999 8),日内精密度RSD为3.7%~5.9%,日间精密度RSD为3.5%~5.7%。绝对回收率为65.0%~72.4%。结论:该法灵敏、准确、简便,检测限低(LOQ),重现性好,可用于血浆头孢地尼浓度的测定。 Objective: To develop a RP-HPLC method for determination the content of cefdinir in human plasma. Method: Arilin was chose as internal standard; The plasma samples were prepared by protein-precipitating using TCA; Chromatographic separation was achieved with a Nucleodur C18 reversed-phase column (250 mm ×4.6 mm, 5 μm) , mobile phase was 0. 025 mol·L -1 ammonium di- hydrogen phosphate ( pH 3.0) and acetonitrile (90.5: 9.5 ), and the flow rate was 1.0 ml· min- 1 ; The detection wavelength was set at 286 nm. Result: The calibration curve was linear over a concentration range of 0.05 - 2.00 μg · ml-1 ( r = 0. 999 8). The RSD of in- tra-day was 3.7% - 5.9% and the RSD of inter-day was 3.5% - 5.7% : The absolute recovery of cefdinir was 65.0% - 72.4%. Conclusion: The sensitive, accurate and convenient method had a low LOQ and a well reproducibility. It can be well applied to the pharmacokinetic study of cefdinir in human plasma.
出处 《中国药师》 CAS 2008年第9期1031-1033,共3页 China Pharmacist
关键词 头孢地尼 反相高效液相色谱 血浆 Cefdinir RP-HPLC Plasma
  • 相关文献

参考文献8

二级参考文献28

  • 1张明发,辛海涛.头孢地尼的临床应用评价[J].中国医院用药评价与分析,2004,4(5):269-273. 被引量:14
  • 2张碧玫,王长力,彭军,姜红,李增彦.高效液相色谱法测定替硝唑乳药浓度[J].中国药学杂志,2004,39(11):850-851. 被引量:4
  • 3刘京,申竹芳,谢明智.HPLC法测定盐酸二甲双胍肠溶胶囊及片剂的人体药代动力学及其生物利用度[J].中国临床药理学杂志,1994,10(3):165-170. 被引量:46
  • 4王金生.新口服头孢菌素头孢克肟和Cefdinir[J].国外医药(抗生素分册),1995,16(6):420-423. 被引量:6
  • 5Fung-Tomc JC,Huczko E,Sticlle T,et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob Agents Chemother, 1995,39 (2) :533.
  • 6Mine Y, Kamimura T, Watanabe Y,et al. In vitro antibacterial activity of FK482, a new orally active cephalosporin. J Antibiotics, 1988,41(12): 1873.
  • 7Wise R,Andrews JM,Thornber D. The in - vitro activity of cefdinir(FK482) ,a new oral cephalosporin. J Antimicrob Chemother,1991,28:239.
  • 8Tack KJ,Keysering CH,Mccarty J, et al. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. Antimicrob Agents Chemother, 1997,41 (4) :739.
  • 9Cook PJ,Andrews JM,Wise R,el al. Distribution of cefdinir, a third generation cephalosporin antibiotic,in serum and pulmonary compartnents. J Antimicrob Chemother, 1996,37: 331.
  • 10Marchese A, Saverino D, Debbia EA,et al. Antistaphylococcal ac tivity of cefdinir, a new oral third - generation cephalosporin , a lone and in combination with other antibiotics, at supra - and sub- MIC levels. J Antimicrob Chemother, 1995,35:53.

共引文献25

同被引文献9

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部